IDEX came into this print already priced as a premium industrial, then tacked on another 1.9% to close at US$233.77 after the release. The stock reaction indicates investors responded positively to the results. The headline is simple: orders and margins did the heavy lifting.

Organic orders rose 28%, with Health and Science Technologies at the center, and adjusted EBITDA margin reached 28.1% in the quarter. Management raised full-year guidance for growth, profitability and earnings. For holders, this update focused less on a single-quarter performance and more on support for a high P/E profile.

Love IDEX's organic order strength and margins but want a broader set of high quality compounders with similar financial traits on your radar? Take a look at the list of solid balance sheet and fundamentals stocks (46 results)

Q2 2026 Earnings Summary

• Total Revenue (Q2 2026 vs. Q2 2025): US$920.6 million vs. US$865.4 million (up about 6%)
• Net Income excl. Extra Items (Q2 2026 vs. Q2 2025): US$143.4 million vs. US$131.6 million (up about 9%)
• Basic EPS (Q2 2026 vs. Q2 2025): US$1.94 vs. US$1.74 (up about 11%)
• Adjusted EBITDA Margin (Q2 2026 vs. Q2 2025): 28.1% vs. about 27.4% (up about 70 bps)

Prefer clean charts instead of another wall of earnings tables and footnotes? Get a full visual view of IDEX, including how its valuation compares with its recent earnings performance, in the company report for IDEX.

IDEX bull case leans on orders and HST mix

Bulls argue that IDEX is becoming a higher growth, higher margin compounder as HST and recent deals like Mott scale and cost programs kick in. Q2 gives that view some concrete wins. Organic orders grew 28% and HST orders rose 47%, with HST revenue up 12% organically and a 270 bps margin expansion plus roughly 40% flow through. Management lifted full year organic growth guidance to 5 to 6% from 3 to 4% and raised margin and EPS ranges, which directly addresses concerns about sluggish organic trends and margin compression in prior years. Orders strength in data center, semiconductor, space, defense and visible backlog into 2027 support the idea of more durable demand in these focus areas. The higher CapEx plan and continued buybacks sit alongside these growth claims rather than replacing them, which is important for a thesis built on organic improvement, not just financial engineering.

Bear case checks tariffs, mix and cyclic exposure

Bears focus on three points for IDEX. Heavy reliance on acquisitions and cost cuts, exposure to cyclical end markets and the risk that premium narrative rests on one time items. Q2 does not fully clear those concerns. FMT revenue grew just 1% organically with a 20 bps margin decline and FSDP sales fell 1% with margins down 50 bps, which fits the story of mixed fundamentals outside HST and pockets of volume deleverage. The IEEPA tariff refund added about 130 bps to adjusted EBITDA margin and US$0.08 to EPS, so headline profitability overstates underlying run rate. Integration and mix risk also remain in view as tariff benefits are largely confined to Q2 and margins in FMT and FSDP did not move up in tandem with group guidance. Stronger orders help but do not yet disprove worries about cyclicality and execution outside the growth platforms.

With IDEX lifting CapEx, leaning on deals, and still carrying a premium P/E, do current cash flows comfortably cover growth plans and potential downturns, or stretch liquidity and leverage more than it appears? Check the financial health analysis of IDEX stock

Stay Ahead With Your IDEX Research

If IDEX's order strength and margin profile has your attention, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch for your preferred entry point. Once you own IDEX or other stocks, use the Portfolio Command Center to cut through noise and focus on the updates that matter for your holdings. For a broader view, tap into the Community to see how other investors are thinking about catalysts, risks and key turning points. This combination helps you surface potential drivers and warning signs early so you can stay ahead of the market.

Seeking Alternatives Beyond IDEX?

Fresh ideas move first. Stocks with real momentum often break out quietly, then start flying once the crowd catches on. Scan these curated lists while it matters and get in early.

• Spot resilient cash generators before they get crowded and review the curated list of solid balance sheet and fundamentals stocks (46 results) that highlights companies with balance sheets built to handle shocks and fund growth.
• Ride structural themes with staying power and scan the hand picked 35 power grid technology and infrastructure stocks capturing companies tied to critical upgrades in energy transmission and grid reliability.
• Catch potential breakout trends early and assess the focused 34 robotics and automation stocks featuring businesses building automation, robotics and production efficiency solutions while they are still under the radar for now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.